$97.5 Billion is the total value of Baillie Gifford's 1147 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HSY | New | Hershey Foods Corporation | $20,435,000 | – | 94,977 | +100.0% | 0.02% | – |
ADM | New | Archer-Daniels-Midland Co | $15,274,000 | – | 196,835 | +100.0% | 0.02% | – |
AZO | New | AutoZone | $4,739,000 | – | 2,205 | +100.0% | 0.01% | – |
FCN | New | FTI Consulting | $5,319,000 | – | 29,413 | +100.0% | 0.01% | – |
CTSH | New | Cognizant Technology Solutions Corpcl a | $4,529,000 | – | 67,105 | +100.0% | 0.01% | – |
New | GitLabclass a | $4,480,000 | – | 84,315 | +100.0% | 0.01% | – | |
MTB | New | M&T Bank Corp | $3,938,000 | – | 24,709 | +100.0% | 0.00% | – |
KMX | New | Carmax Inc | $4,035,000 | – | 44,597 | +100.0% | 0.00% | – |
PCAR | New | Paccar | $3,513,000 | – | 42,668 | +100.0% | 0.00% | – |
PGR | New | Progressive | $3,924,000 | – | 33,746 | +100.0% | 0.00% | – |
GMED | New | Globus Medicalcl a | $3,597,000 | – | 64,077 | +100.0% | 0.00% | – |
TXN | New | Texas Instruments | $3,697,000 | – | 24,059 | +100.0% | 0.00% | – |
CRL | New | Charles River Laboratories International | $3,380,000 | – | 15,796 | +100.0% | 0.00% | – |
SBNY | New | Signature Bank | $1,792,000 | – | 10,002 | +100.0% | 0.00% | – |
APRN | New | Blue Apron Holdings Inccl a | $541,000 | – | 148,506 | +100.0% | 0.00% | – |
APLS | New | Apellis Pharmaceuticals | $13,000 | – | 283 | +100.0% | 0.00% | – |
BC | New | Brunswick Corp | $13,000 | – | 200 | +100.0% | 0.00% | – |
CRH | New | CRH Plc ADRadr | $2,000 | – | 60 | +100.0% | 0.00% | – |
COIN | New | Coinbase Global Inc | $350,000 | – | 7,447 | +100.0% | 0.00% | – |
New | Quidel Corp | $12,000 | – | 128 | +100.0% | 0.00% | – | |
CYTK | New | Cytokinetics Inc | $13,000 | – | 340 | +100.0% | 0.00% | – |
DG | New | Dollar General Corp | $17,000 | – | 69 | +100.0% | 0.00% | – |
FATE | New | Fate Therapeutics | $9,000 | – | 372 | +100.0% | 0.00% | – |
New | Lightspeed POS | $7,000 | – | 310 | +100.0% | 0.00% | – | |
LECO | New | Lincoln Electric Holdings Inc | $11,000 | – | 91 | +100.0% | 0.00% | – |
MRTX | New | Mirati Therapeutics | $13,000 | – | 196 | +100.0% | 0.00% | – |
MNTV | New | Momentive Global Inc | $10,000 | – | 1,095 | +100.0% | 0.00% | – |
RIO | New | Rio Tinto Spn.Adr 1:1sponsored adr | $2,000 | – | 38 | +100.0% | 0.00% | – |
SGMO | New | Sangamo Biosciences | $10,000 | – | 2,510 | +100.0% | 0.00% | – |
AOS | New | A. O. Smith | $14,000 | – | 263 | +100.0% | 0.00% | – |
TCEHY | New | Tencent ADRspon adr | $3,000 | – | 66 | +100.0% | 0.00% | – |
WST | New | West Pharmaceutical Services | $12,000 | – | 40 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-08
About Baillie Gifford
Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.
Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.
One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.
Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Amazon.Com | 42 | Q3 2023 | 10.0% |
Tesla Motors | 42 | Q3 2023 | 10.7% |
Illumina | 42 | Q3 2023 | 6.6% |
Baidu.com Sponsored ADR | 42 | Q3 2023 | 11.6% |
Meta Platforms Inc | 42 | Q3 2023 | 5.0% |
MercadoLibre | 42 | Q3 2023 | 7.3% |
Intuitive Surgical | 42 | Q3 2023 | 3.5% |
Moody's Corp | 42 | Q3 2023 | 1.4% |
MasterCard Inc-Class A | 42 | Q3 2023 | 1.9% |
Workday Inc | 42 | Q3 2023 | 1.4% |
View Baillie Gifford's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Oddity Tech Ltd | September 07, 2023 | 4,914,661 | 10.9% |
Roblox Corp | September 07, 2023 | 28,106,215 | 5.0% |
SiteOne Landscape Supply, Inc. | August 03, 2023 | 2,234,985 | 5.0% |
UPWORK, INC | August 03, 2023 | 6,565,230 | 4.9% |
CHINOOK THERAPEUTICS, INC. | August 01, 2023 | 844,684 | 2.0% |
MELI Kaszek Pioneer CorpSold out | July 05, 2023 | 0 | 0.0% |
Abcam plc | June 08, 2023 | 11,331,726 | 4.9% |
CARVANA CO. | June 06, 2023 | 61,989 | 0.1% |
EverQuote, Inc. | May 03, 2023 | 1,358,439 | 5.0% |
CEMEX SAB DE CV | March 03, 2023 | 752,914,110 | 5.0% |
View Baillie Gifford's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-04-04 |
SC 13G/A | 2024-04-04 |
SC 13G/A | 2024-03-07 |
SC 13G/A | 2024-03-06 |
SC 13G/A | 2024-02-07 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-02-01 |
SC 13G/A | 2024-01-30 |
SC 13G/A | 2024-01-30 |
SC 13G/A | 2024-01-30 |
View Baillie Gifford's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.